NCT07432594 2026-02-25
Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Not yet recruiting
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
University of Pittsburgh
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
FutureGen Biopharmaceutical (Beijing) Co., Ltd